Location: Lorient
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Lorient
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma Phase 3 · Groupement Hospitalier Bretagne Sud · Federation Francophone de Cancerologie Digestive · NCT07270991 FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum Phase 2 · Groupe Hospitalier Bretagne Sud · Centre Leon Berard · NCT06393816 Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype Phase 3 · AUB Santé foundation, Lorient · University Hospital, Tours · NCT05732727 Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers Phase 3 · Groupe Hospitalier Bretagne Sud · UNICANCER · NCT04747054 Skipping Hormone Therapy in Low-Risk Early Breast Cancer Phase 2 · Groupe Hospitalier Bretagne Sud · UNICANCER · NCT07661927 Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carci Phase 3 · Groupe Hospitalier Bretagne Sud · Centre Leon Berard · NCT06692556 Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study NA · CHBS Lorient · University Hospital, Brest · NCT05015153 Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy f Phase 3 · Lorient - Groupe Hospitalier Bretagne Sud - Site Du Scorff · Federation Francophone de Cancerologie Digestive · NCT06207981 Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metast NA · Groupement Hospitalier Bretagne Sud · Federation Francophone de Cancerologie Digestive · NCT07124858 Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC NA · Hôpital du Scorff · Groupe Francais De Pneumo-Cancerologie · NCT05122806 Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe At Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06947993 Study of Alloknesia in Atopic Dermatitis Phase N/A · Groupe Hospitalier Bretagne Sud · University Hospital, Brest · NCT06923202 Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the C Phase N/A · CH bretagne sud · Nantes University Hospital · NCT04352036 AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer Phase N/A · Clinique Mutualiste de la porte de l'Orient · Association Francaise d'Urologie · NCT05002556 Outpatient Management of Primary Spontaneous Pneumothorax: Pigtail Catheter With Unidirectional Valve vs. Exsufflation, NA · CH Lorient · Rennes University Hospital · NCT03691480 Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamid Phase 3 · GHBS - Hôpital du Scorff · Alianza multidisciplinar para la investigación de los tumore · NCT07333066 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina Phase 2/Phase 3 · Local Institution - 007-1993 · Mirati Therapeutics Inc. · NCT04613596 Met Non Small Cell Cancer Registry (MOMENT) Phase N/A · Hôpital du Scorff · EMD Serono Research & Development Institute, Inc. · NCT05376891 Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Ster NA · Groupe hospitalier Bretagne Sud · Centre Francois Baclesse · NCT05102747 A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo Phase N/A · Centre Hospitalier de Bretagne Sud /ID# 277559 · AbbVie · NCT07136467 Bougie Versus Endotracheal Tube Alone on First-attempt Intubation Success in Prehospital Emergency Intubation (BETA Tria NA · CH de Lorient · Nantes University Hospital · NCT06307392 Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities NA · CH de Lorient · Nantes University Hospital · NCT06581939 A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat Phase 2/Phase 3 · Local Institution - 0618 · Bristol-Myers Squibb · NCT07221357 Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study) Phase N/A · Hôpital du Scorff · GFPC Investigation · NCT07243132 Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation Phase N/A · CH Bretagne Sud · University Hospital, Brest · NCT05197387 Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First L Phase 3 · Hôpital du Scorff · Federation Francophone de Cancerologie Digestive · NCT02885753 Impact of the Therapeutic Education Program "living with a Chronic Inflammatory Disease Under Biotherapy" on Patient Com Phase N/A · Groupe Hospitalier de Bretagne Sud · Groupe Hospitalier de Bretagne Sud · NCT06620770 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy Phase 3 · Research Site · AstraZeneca · NCT05774951 Ziconotide for Non-cancer Pain by Intrathecal Administration Phase N/A · Clinique Mutualiste de la Porte de l'Orient · ESTEVE Pharmaceuticals SAS · NCT06541184 Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ? Phase N/A · CH Bretagne Sud, Lorient · Rennes University Hospital · NCT03687528
Look up another city
Look up another condition